Glioblastoma Multiforme: Clinical Trials

3 trials for Glioblastoma Multiforme, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Suspended 3
Phase 23Suspended 3

Follow Glioblastoma Multiforme: new trials by email Literature Review of Glioblastoma Multiforme trials Research Report on Glioblastoma Multiforme

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
NaviFUS System, Lumason, Bevacizumab - Glioblastoma Multiforme, Glioblastoma
Phase 1 / Phase 2SuspendedNaviFUS Corporation102024-10-222026-09-09
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
TPI 287, Bevacizumab - Glioblastoma Multiforme
Phase 1 / Phase 2SuspendedCortice Biosciences, Inc.922013-08-012023-02-22
Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Bevacizumab and Carboplatin - Glioblastoma Multiforme, Anaplastic Astrocytoma
Phase 1 / Phase 2SuspendedNorthwell Health542011-09-012026-06-01

Narrower conditions

Glioblastoma (3)  ·  Neoplasms (2)  ·  Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Glioma (1)  ·  Neoplasms, Nerve Tissue (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Astrocytoma (2)  ·  Glioma (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)

Interventions

Bevacizumab (3)  ·  Carboplatin (1)  ·  TPI-287 (1)  ·  contrast agent BR1 (1)

Sponsors

Cortice Biosciences, Inc. (1)  ·  NaviFUS Corporation (1)  ·  Northwell Health (1)

Countries

United States (3)

Top investigators

J. P. Duic, M.D. (1)  ·  Jian Campian, M.D. (1)  ·  John Boockvar, MD (1)  ·  Louis B. Nabors, III, M.D. (1)  ·  Nimish Mohile, M.D. (1)  ·  Pierre Giglio, M.D. (1)  ·  Samuel A. Goldlust, M.D. (1)  ·  Sigmund Hsu, M.D. (1)  ·  Tara L. Benkers, M.D. (1)